نتایج جستجو برای: hyposmia

تعداد نتایج: 373  

2015
Eike Wehling Halvor Naess Daniel Wollschlaeger Hakon Hofstad Annika Bramerson Mats Bende Steven Nordin

BACKGROUND The aim of the study was to investigate odor identification performance in patients one year after hospital admittance due to stroke. Predictors for olfactory dysfunction were investigated as well as self-reported olfactory function and pleasantness of olfactory items. METHODS A 1-year prospective study was performed. Stroke location, classification and comorbidities were registere...

2017
Christian Pifl Harald Reither Natalia Lopez-Gonzalez del Rey Carmen Cavada Jose A. Obeso Javier Blesa

Parkinson's disease (PD) is a neurodegenerative disease with both motor and non-motor manifestations. Hyposmia is one of the early non-motor symptoms, which can precede motor symptoms by several years. The relationship between hyposmia and PD remains elusive. Olfactory bulb (OB) pathology shows an increased number of olfactory dopaminergic cells, protein aggregates and dysfunction of neurotrans...

2014
Gilles Klein Lothar Burghaus Michel Vaillant Vannina Pieri Gereon R. Fink Nico Diederich

BACKGROUND AND PURPOSE Excessive daytime sleepiness and sudden sleep attacks are the main features of narcolepsy, but rapid-eye-movement sleep behavior disorder (RBD), hyposmia, and depression can also occur. The latter symptoms are nonmotor features in idiopathic Parkinson's disease (IPD). In the present study, IPD-proven diagnostic tools were tested to determine whether they are also applicab...

Journal: :Brazilian journal of otorhinolaryngology 2017
Ricardo Landini Lutaif Dolci Marcel Menon Miyake Daniela Akemi Tateno Natalia Amaral Cançado Carlos Augusto Correia Campos Américo Rubens Leite Dos Santos Paulo Roberto Lazarini

INTRODUCTION The large increase in the number of transnasal endoscopic skull base surgeries is a consequence of greater knowledge of the anatomic region, the development of specific materials and instruments, and especially the use of the nasoseptal flap as a barrier between the sinus tract (contaminated cavity) and the subarachnoid space (sterile area), reducing the high risk of contamination....

2013
Elisa Della Valle Silvia Vezzani Vincenzo Rochira Antonio Raffaele Michele Granata Bruno Madeo Elisabetta Genovese Elisa Pignatti Marco Marino Cesare Carani Manuela Simoni

INTRODUCTION Hypogonadotropic hypogonadism (HH) is a heterogeneous disease caused by mutations in several genes. Based on the presence of hyposmia/anosmia it is distinguished into Kallmann syndrome (KS) and isolated HH. The prevalence of other developmental anomalies is not well established. METHODS We studied 36 patients with HH (31 males, 5 females, mean age 41.5), 9 with familial and 27 wi...

2017
Isabel Ubeda-Bañon Alicia Flores-Cuadrado Daniel Saiz-Sanchez Alino Martinez-Marcos

Synucleinopathies (including α-synucleinopathies), which include Parkinson's disease (PD), manifest themsevles early on (stage 1) in the olfactory system; preferentially in the anterior olfactory nucleus (AON). In particular, the non-motor, early manifestations of PD include hyposmia, which is the partial loss of the sense of smell. The neural basis of hyposmia in PD, however, is poorly underst...

Journal: :Headache 2016
Nils Becker Golo Kronenberg Lutz Harms Edzard Wiener Katharina Kreutz Atef Eltiri Felix Schmidt Jan Hoffmann Hagen Kunte

Idiopathic intracranial hypertension (IIH), also known as pseudotumor cerebri, preferentially affects obese women of childbearing age. Although the precise etiology of IIH remains to be fully established, elevated intracranial pressure (ICP) clearly constitutes a hallmark pathologic feature of the condition. Affected individuals regularly suffer from signs and symptoms of increased ICP such as ...

Journal: :Journal of investigational allergology & clinical immunology 2010
N G Sousa E Faria I Carrapatoso E Almeida L Geraldes C Chieira

improvement in nasal symptoms (congestion and hydrorrhea, and, to a lesser extent, hyposmia); 2 months later she had also achieved better asthma control (no further need for rescue bronchodilator use and no asthma symptoms, leading to the withdrawal of inhaled corticosteroids and long-acting ß 2 agonists, and a signifi cant improvement of FEV 1 up to 90% of predicted). After 16 weeks of treatme...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید